Esperion Therapeutics (ESPR) PT Lowered to $27 at JMP Securities, Following Strategic Business Update
Tweet Send to a Friend
JMP Securities analyst Jason N. Butler lowered the price target on Esperion Therapeutics (NASDAQ: ESPR) to $27.00 (from $90.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
